Thyrocare Technologies · NSE: THYROCARE · BSE: 539871
Q3 FY23 results · Oct–Dec 2022
Thyrocare Technologies reported revenue from operations of ₹128.03 crore (up 9.1% from Q3 FY22) and net profit of ₹14.70 crore (down 31.6% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 128.03 | 117.40 | +9.1% | 134.97 | −5.1% |
| Other income | 2.10 | 1.40 | +50.0% | 1.62 | +29.6% |
| Total income | 130.13 | 118.80 | +9.5% | 136.59 | −4.7% |
| Profit before tax | 19.72 | 28.90 | −31.8% | 23.51 | −16.1% |
| Net profit for the period | 14.70 | 21.50 | −31.6% | 15.43 | −4.7% |
| EPS, basic (₹) | 1.89 | 4.05 | −53.3% | 3.80 | −50.3% |
| Net margin (%) | 11.5 | 18.3 | 11.4 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 117.17 | 110.20 | +6.3% | 125.23 | −6.4% |
| Other income | 1.27 | 1.10 | +15.5% | 1.16 | +9.5% |
| Total income | 118.44 | 111.30 | +6.4% | 126.39 | −6.3% |
| Profit before tax | 17.58 | 29.10 | −39.6% | 22.12 | −20.5% |
| Net profit for the period | 12.63 | 22.60 | −44.1% | 14.30 | −11.7% |
| EPS, basic (₹) | 2.38 | 4.28 | −44.4% | 2.70 | −11.9% |
| Net margin (%) | 10.8 | 20.5 | 11.4 |
Consolidated
- Filed with BSE
- 04 Feb 2023, 17:02 IST
- Board meeting
- 03 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2023, 17:02 IST
- Board meeting
- 03 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE